Detalhe da pesquisa
1.
Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report.
Blood
; 142(3): 221-229, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070673
2.
Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report.
Cancer
; 129(1): 151-160, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369905
3.
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.
Pediatr Blood Cancer
; 69(5): e29601, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187850
4.
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Lancet Oncol
; 20(10): 1420-1431, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471158
5.
Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma.
Br J Haematol
; 185(6): 1055-1070, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613939
6.
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.
Blood
; 129(14): 1919-1926, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153823
7.
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
Pediatr Blood Cancer
; 66(8): e27770, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012208
8.
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Blood
; 127(13): 1656-65, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825712
9.
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
J Neurooncol
; 140(3): 717-725, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392092
10.
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Br J Haematol
; 179(5): 739-747, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082519
11.
Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.
Pediatr Blood Cancer
; 64(7)2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27957801
12.
Natural killer/T-cell lymphomas in pediatric and adolescent patients.
Clin Adv Hematol Oncol
; 15(3): 200-209, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28398275
13.
Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.
Pediatr Blood Cancer
; 63(5): 794-800, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26728447
14.
The importance of assessing priorities of reproductive health concerns among adolescent and young adult patients with cancer.
Cancer
; 121(15): 2529-36, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26054052
15.
Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia.
Blood
; 121(21): 4348-54, 2013 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568490
16.
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group.
Br J Haematol
; 162(6): 792-801, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23889312
17.
Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease.
Pediatr Blood Cancer
; 60(12): 1936-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24039121
18.
Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study.
J Clin Oncol
; 41(14): 2638-2650, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693221
19.
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
Invest New Drugs
; 30(3): 916-26, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21340507
20.
Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.
Pediatr Blood Cancer
; 59(4): 762-4, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378696